Biotechnology company that developed mRNA-based pathway activity profiling and structured machine-learning technology to quantify disease-driving signaling pathways
Biotechnology company that developed mRNA-based pathway activity profiling and structured machine-learning technology to quantify disease-driving signaling pathways. Its platform supported diagnostics, precision medicine, oncology research, and drug discovery. The company has ended its activities.